{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T04:44:41Z","timestamp":1772340281345,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2024-00338906"],"award-info":[{"award-number":["RS-2024-00338906"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-16229-5","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T20:18:46Z","timestamp":1755548326000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Risks of cataract surgery in solid and hematologic cancer survivors"],"prefix":"10.1038","volume":"15","author":[{"given":"Hyunjean","family":"Jung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunyeup","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byoung Hyuck","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher Seungkyu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suk Ho","family":"Byeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5632-5208","authenticated-orcid":false,"given":"Seung Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6090-2549","authenticated-orcid":false,"given":"Yong Joon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,18]]},"reference":[{"key":"16229_CR1","doi-asserted-by":"publisher","first-page":"301","DOI":"10.4143\/crt.2021.291","volume":"53","author":"S Hong","year":"2021","unstructured":"Hong, S. et al. Cancer statistics in korea: incidence, mortality, survival, and prevalence in 2018. Cancer Res. Treat. 53, 301\u2013315. https:\/\/doi.org\/10.4143\/crt.2021.291 (2021).","journal-title":"Cancer Res. Treat."},{"key":"16229_CR2","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3988\/jcn.2021.17.2.249","volume":"17","author":"JW Jang","year":"2021","unstructured":"Jang, J. W. et al. Prevalence and incidence of dementia in South korea: A nationwide analysis of the National health insurance service senior cohort. J. Clin. Neurol. (Seoul Korea). 17, 249\u2013256. https:\/\/doi.org\/10.3988\/jcn.2021.17.2.249 (2021).","journal-title":"J. Clin. Neurol. (Seoul Korea)"},{"key":"16229_CR3","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ijcard.2020.04.080","volume":"317","author":"JC Youn","year":"2020","unstructured":"Youn, J. C. et al. Cardiovascular disease burden in adult patients with cancer: an 11-year nationwide population-based cohort study. Int. J. Cardiol. 317, 167\u2013173. https:\/\/doi.org\/10.1016\/j.ijcard.2020.04.080 (2020).","journal-title":"Int. J. Cardiol."},{"key":"16229_CR4","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1002\/ijc.10981","volume":"104","author":"PN Schultz","year":"2003","unstructured":"Schultz, P. N., Beck, M. L. & Stava, C. Vassilopoulou-Sellin, R. Health profiles in 5836 long-term cancer survivors. Int. J. Cancer. 104, 488\u2013495. https:\/\/doi.org\/10.1002\/ijc.10981 (2003).","journal-title":"Int. J. Cancer"},{"key":"16229_CR5","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/pbc.22277","volume":"54","author":"KF Whelan","year":"2010","unstructured":"Whelan, K. F. et al. Ocular late effects in childhood and adolescent cancer survivors: a report from the childhood cancer survivor study. Pediatr. Blood Cancer. 54, 103\u2013109. https:\/\/doi.org\/10.1002\/pbc.22277 (2010).","journal-title":"Pediatr. Blood Cancer"},{"key":"16229_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2023.06.007","author":"CJ Shen","year":"2023","unstructured":"Shen, C. J. et al. Optic neuropathy, and cataract in childhood cancer survivors treated with radiation therapy: A PENTEC comprehensive review. Int. J. Radiation Oncology*Biology*Physics. https:\/\/doi.org\/10.1016\/j.ijrobp.2023.06.007 (2023). Retinopathy.","journal-title":"Int. J. Radiation Oncology*Biology*Physics"},{"key":"16229_CR7","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1667\/rr14276.1","volume":"185","author":"G Chodick","year":"2016","unstructured":"Chodick, G. et al. The risk of cataract among survivors of childhood and adolescent cancer: A report from the childhood cancer survivor study. Radiat. Res. 185, 366\u2013374. https:\/\/doi.org\/10.1667\/rr14276.1 (2016).","journal-title":"Radiat. Res."},{"key":"16229_CR8","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1097\/01.coc.0000175291.51232.48","volume":"28","author":"C Stava","year":"2005","unstructured":"Stava, C., Beck, M. & Vassilopoulou-Sellin, R. Cataracts among cancer survivors. Am. J. Clin. Oncol. 28, 603\u2013608. https:\/\/doi.org\/10.1097\/01.coc.0000175291.51232.48 (2005).","journal-title":"Am. J. Clin. Oncol."},{"key":"16229_CR9","doi-asserted-by":"publisher","first-page":"e144","DOI":"10.1016\/s2214-109x(20)30489-7","volume":"9","author":"Causes of blindness and vision impairment","year":"2021","unstructured":"Causes of blindness and vision impairment. In 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the right to sight: an analysis for the global burden of disease study. Lancet Global Health. 9, e144\u2013e160. https:\/\/doi.org\/10.1016\/s2214-109x(20)30489-7 (2021).","journal-title":"Lancet Global Health"},{"key":"16229_CR10","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1002\/(SICI)1097-0142(19961001)78:7<1359::AID-CNCR1>3.0.CO;2-G","volume":"78","author":"T al-Tweigeri","year":"1996","unstructured":"al-Tweigeri, T., Nabholtz, J. M. & Mackey, J. R. Ocular toxicity and cancer chemotherapy. A review. Cancer 78, 1359\u20131373. (1996).","journal-title":"Cancer"},{"key":"16229_CR11","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s40265-021-01507-z","volume":"81","author":"BH Fortes","year":"2021","unstructured":"Fortes, B. H., Tailor, P. D. & Dalvin, L. A. Ocular toxicity of targeted anticancer agents. Drugs 81, 771\u2013823. https:\/\/doi.org\/10.1007\/s40265-021-01507-z (2021).","journal-title":"Drugs"},{"key":"16229_CR12","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/cncr.21651","volume":"106","author":"L Gianni","year":"2006","unstructured":"Gianni, L. et al. Ocular toxicity during adjuvant chemoendocrine therapy for early breast cancer: results from international breast cancer study group trials. Cancer 106, 505\u2013513. https:\/\/doi.org\/10.1002\/cncr.21651 (2006).","journal-title":"Cancer"},{"key":"16229_CR13","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1136\/bmj.1.5794.218","volume":"1","author":"MP Ravindranathan","year":"1972","unstructured":"Ravindranathan, M. P., Paul, V. J. & Kuriakose, E. T. Cataract after Busulphan treatment. Br. Med. J. 1, 218\u2013219. https:\/\/doi.org\/10.1136\/bmj.1.5794.218 (1972).","journal-title":"Br. Med. J."},{"key":"16229_CR14","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1056\/NEJMoa1400376","volume":"371","author":"JC Byrd","year":"2014","unstructured":"Byrd, J. C. et al. Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia. N. Engl. J. Med. 371, 213\u2013223. https:\/\/doi.org\/10.1056\/NEJMoa1400376 (2014).","journal-title":"N. Engl. J. Med."},{"key":"16229_CR15","doi-asserted-by":"publisher","first-page":"e016640","DOI":"10.1136\/bmjopen-2017-016640","volume":"7","author":"SC Seong","year":"2017","unstructured":"Seong, S. C. et al. Cohort profile: the National health insurance Service-National health screening cohort (NHIS-HEALS) in Korea. BMJ Open. 7, e016640. https:\/\/doi.org\/10.1136\/bmjopen-2017-016640 (2017).","journal-title":"BMJ Open."},{"key":"16229_CR16","doi-asserted-by":"publisher","unstructured":"Shin, J., Bae, Y. J. & Kang, H. T. Insurance types and All-Cause mortality in Korean cancer patients: A nationwide Population-Based cohort study. J. Pers. Med. 14 https:\/\/doi.org\/10.3390\/jpm14080861 (2024).","DOI":"10.3390\/jpm14080861"},{"key":"16229_CR17","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1093\/aje\/kwq224","volume":"172","author":"PC Austin","year":"2010","unstructured":"Austin, P. C. Statistical criteria for selecting the optimal number of untreated subjects matched to each treated subject when using many-to-one matching on the propensity score. Am. J. Epidemiol. 172, 1092\u20131097. https:\/\/doi.org\/10.1093\/aje\/kwq224 (2010).","journal-title":"Am. J. Epidemiol."},{"key":"16229_CR18","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1097\/sla.0000000000001360","volume":"263","author":"J Datta","year":"2016","unstructured":"Datta, J. et al. Implications of lymph node staging on selection of adjuvant therapy for gastric cancer in the united states: A propensity Score-matched analysis. Ann. Surg. 263, 298\u2013305. https:\/\/doi.org\/10.1097\/sla.0000000000001360 (2016).","journal-title":"Ann. Surg."},{"key":"16229_CR19","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s11764-021-01150-3","volume":"17","author":"E Choi","year":"2023","unstructured":"Choi, E., Becker, H. & Jung, H. Health-related quality of life in adolescents and young adults with and without cancer, using propensity score matching. J. Cancer Survivorship: Res. Pract. 17, 279\u2013289. https:\/\/doi.org\/10.1007\/s11764-021-01150-3 (2023).","journal-title":"J. Cancer Survivorship: Res. Pract."},{"key":"16229_CR20","doi-asserted-by":"publisher","first-page":"11639","DOI":"10.1038\/s41598-021-91131-4","volume":"11","author":"S Scomersi","year":"2021","unstructured":"Scomersi, S. et al. Comparison between male and female breast cancer survival using propensity score matching analysis. Sci. Rep. 11, 11639. https:\/\/doi.org\/10.1038\/s41598-021-91131-4 (2021).","journal-title":"Sci. Rep."},{"key":"16229_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1089\/jop.2005.21.11","volume":"21","author":"ER James","year":"2005","unstructured":"James, E. R., Fresco, V. M. & Robertson, L. L. Glucocorticoid-induced changes in the global gene expression of lens epithelial cells. J. Ocular Pharmacol. Therapeutics: Official J. Association Ocular Pharmacol. Ther. 21, 11\u201327. https:\/\/doi.org\/10.1089\/jop.2005.21.11 (2005).","journal-title":"J. Ocular Pharmacol. Therapeutics: Official J. Association Ocular Pharmacol. Ther."},{"key":"16229_CR22","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1089\/jop.2006.0067","volume":"23","author":"ER James","year":"2007","unstructured":"James, E. R. The etiology of steroid cataract. J. Ocular Pharmacol. Therapeutics: Official J. Association Ocular Pharmacol. Ther. 23, 403\u2013420. https:\/\/doi.org\/10.1089\/jop.2006.0067 (2007).","journal-title":"J. Ocular Pharmacol. Therapeutics: Official J. Association Ocular Pharmacol. Ther."},{"key":"16229_CR23","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/s0161-6420(99)90454-2","volume":"106","author":"DW Suh","year":"1999","unstructured":"Suh, D. W., Ruttum, M. S., Stuckenschneider, B. J., Mieler, W. F. & Kivlin, J. D. Ocular findings after bone marrow transplantation in a pediatric population. Ophthalmology 106, 1564\u20131570. https:\/\/doi.org\/10.1016\/s0161-6420(99)90454-2 (1999).","journal-title":"Ophthalmology"},{"key":"16229_CR24","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1136\/bjo.77.1.36","volume":"77","author":"BM Calissendorff","year":"1993","unstructured":"Calissendorff, B. M. & Bolme, P. Cataract development and outcome of surgery in bone marrow transplanted children. Br. J. Ophthalmol. 77, 36\u201338. https:\/\/doi.org\/10.1136\/bjo.77.1.36 (1993).","journal-title":"Br. J. Ophthalmol."},{"key":"16229_CR25","first-page":"427","volume":"7","author":"B Calissendorff","year":"1991","unstructured":"Calissendorff, B., Bolme, P. & el Azazi, M. The development of cataract in children as a late side-effect of bone marrow transplantation. Bone Marrow Transplant. 7, 427\u2013429 (1991).","journal-title":"Bone Marrow Transplant."},{"key":"16229_CR26","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1001\/jama.1995.03530160041031","volume":"274","author":"WD Haire","year":"1995","unstructured":"Haire, W. D. et al. Multiple organ dysfunction syndrome in bone marrow transplantation. Jama 274, 1289\u20131295 (1995).","journal-title":"Jama"},{"key":"16229_CR27","doi-asserted-by":"publisher","first-page":"3501","DOI":"10.1182\/blood-2004-01-0200","volume":"104","author":"BL Stewart","year":"2004","unstructured":"Stewart, B. L. et al. Duration of immunosuppressive treatment for chronic graft-versus-host disease. Blood 104, 3501\u20133506. https:\/\/doi.org\/10.1182\/blood-2004-01-0200 (2004).","journal-title":"Blood"},{"key":"16229_CR28","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1177\/2040620713489842","volume":"4","author":"C Garnett","year":"2013","unstructured":"Garnett, C., Apperley, J. F. & Pavl\u016f, J. Treatment and management of graft-versus-host disease: improving response and survival. Therapeutic Adv. Hematol. 4, 366\u2013378. https:\/\/doi.org\/10.1177\/2040620713489842 (2013).","journal-title":"Therapeutic Adv. Hematol."},{"key":"16229_CR29","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1038\/s41409-019-0434-3","volume":"54","author":"SI Fujiwara","year":"2019","unstructured":"Fujiwara, S. I. et al. Clinical significance of low-dose total body irradiation in HLA-mismatched reduced-intensity stem cell transplantation. Bone Marrow Transplant. 54, 1327\u20131336. https:\/\/doi.org\/10.1038\/s41409-019-0434-3 (2019).","journal-title":"Bone Marrow Transplant."},{"key":"16229_CR30","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/s0360-3016(96)85011-5","volume":"35","author":"Y Belkac\u00e9mi","year":"1996","unstructured":"Belkac\u00e9mi, Y. et al. Cataractogenesis after total body irradiation. Int. J. Radiat. Oncol. Biol. Phys. 35, 53\u201360. https:\/\/doi.org\/10.1016\/s0360-3016(96)85011-5 (1996).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"16229_CR31","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/0958-3947(95)02050-0","volume":"21","author":"C Reft","year":"1996","unstructured":"Reft, C., Rash, C., Dabrowski, J., Roeske, J. C. & Hallahan, D. Eye shielding for patients treated with total body irradiation. Med. Dosimetry: Official J. Am. Association Med. Dosimetrists. 21, 73\u201378. https:\/\/doi.org\/10.1016\/0958-3947(95)02050-0 (1996).","journal-title":"Med. Dosimetry: Official J. Am. Association Med. Dosimetrists"},{"key":"16229_CR32","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1001\/jamaophthalmol.2015.6088","volume":"134","author":"RS Allodji","year":"2016","unstructured":"Allodji, R. S. et al. Association of radiation dose to the eyes with the risk for cataract after nonretinoblastoma solid cancers in childhood. JAMA Ophthalmol. 134, 390\u2013397. https:\/\/doi.org\/10.1001\/jamaophthalmol.2015.6088 (2016).","journal-title":"JAMA Ophthalmol."},{"key":"16229_CR33","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3857\/roj.2023.00871","volume":"42","author":"J Kwon","year":"2024","unstructured":"Kwon, J. & Kim, B. H. Long-term toxicities after allogeneic hematopoietic stem cell transplantation with or without total body irradiation: a population-based study in Korea. Radiation Oncol. J. 42, 50\u201362. https:\/\/doi.org\/10.3857\/roj.2023.00871 (2024).","journal-title":"Radiation Oncol. J."},{"key":"16229_CR34","doi-asserted-by":"publisher","first-page":"903","DOI":"10.3390\/curroncol28010089","volume":"28","author":"M Sabloff","year":"2021","unstructured":"Sabloff, M., Tisseverasinghe, S., Babadagli, M. E. & Samant, R. Total body irradiation for hematopoietic stem cell transplantation: what can we agree on? Curr. Oncol. (Toronto Ont). 28, 903\u2013917. https:\/\/doi.org\/10.3390\/curroncol28010089 (2021).","journal-title":"Curr. Oncol. (Toronto Ont)"},{"key":"16229_CR35","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1200\/jco.1997.15.7.2644","volume":"15","author":"JM Mitchell","year":"1997","unstructured":"Mitchell, J. M., Meehan, K. R., Kong, J. & Schulman, K. A. Access to bone marrow transplantation for leukemia and lymphoma: the role of sociodemographic factors. J. Clin. Oncology: Official J. Am. Soc. Clin. Oncol. 15, 2644\u20132651. https:\/\/doi.org\/10.1200\/jco.1997.15.7.2644 (1997).","journal-title":"J. Clin. Oncology: Official J. Am. Soc. Clin. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16229-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16229-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16229-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T05:37:40Z","timestamp":1757396260000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16229-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,18]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["16229"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-16229-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,18]]},"assertion":[{"value":"2 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30263"}}